10-49131671-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001164484.2(FAM170B):c.794G>A(p.Ser265Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,551,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001164484.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM170B | ENST00000311787.6 | c.794G>A | p.Ser265Asn | missense_variant | Exon 2 of 2 | 1 | NM_001164484.2 | ENSP00000308292.6 | ||
FAM170B-AS1 | ENST00000435809.1 | n.192-4206C>T | intron_variant | Intron 1 of 2 | 3 | |||||
FAM170B-AS1 | ENST00000442525.5 | n.439-3985C>T | intron_variant | Intron 1 of 5 | 2 | |||||
FAM170B-AS1 | ENST00000443389.5 | n.433+9395C>T | intron_variant | Intron 1 of 5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000449 AC: 7AN: 155994Hom.: 0 AF XY: 0.0000484 AC XY: 4AN XY: 82706
GnomAD4 exome AF: 0.0000164 AC: 23AN: 1399422Hom.: 0 Cov.: 30 AF XY: 0.0000159 AC XY: 11AN XY: 690218
GnomAD4 genome AF: 0.000171 AC: 26AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.794G>A (p.S265N) alteration is located in exon 2 (coding exon 2) of the FAM170B gene. This alteration results from a G to A substitution at nucleotide position 794, causing the serine (S) at amino acid position 265 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at